Sort   by:  
 Page size 
UnknownPrediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.
Not available
S-EPMC5012662 | biostudies-literature
UnknownPhase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Not available
S-EPMC7211198 | biostudies-literature
UnknownClinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.
Not available
S-EPMC12267046 | biostudies-literature
UnknownA Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
Not available
S-EPMC10842136 | biostudies-literature
UnknownG-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.
Not available
S-EPMC10314699 | biostudies-literature
UnknownAltered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.
Not available
S-EPMC8028848 | biostudies-literature
UnknownPostdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.
Not available
S-EPMC6891169 | biostudies-literature
UnknownA blood-based metabolomic signature predictive of risk for pancreatic cancer.
Not available
S-EPMC10518621 | biostudies-literature
UnknownPancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Not available
S-EPMC2943735 | biostudies-literature
UnknownThe age-dependent association of risk factors with pancreatic cancer.
Not available
S-EPMC9233063 | biostudies-literature
Sort   by:  
 Page size